NCT04165928

Brief Summary

Background: Tetanus is a life-threatening disease in developing countries, and accompanied by a high mortality rate. China is the world's largest developing country, and Fujian Province is a typical coastal province in China with a relatively developed economy. Therefore, the purpose of this study was to investigate the epidemiology, incidence and management of tetanus in Fujian Province and to understand the current treatment and prognosis of tetanus patients in China. Methods: This was a retrospective multicenter observational study of patients who presented with a clinical diagnosis of tetanus at 5 general hospitals in Fujian. Data was analyzed using computer software system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 18, 2019

Completed
Last Updated

November 18, 2019

Status Verified

November 1, 2019

Enrollment Period

1.2 years

First QC Date

November 13, 2019

Last Update Submit

November 14, 2019

Conditions

Tetanus

Keywords

neonatal tetanustetanus immunization programdrug-inducedtetanus antitoxincritical care medicineartificial airway

Outcome Measures

Primary Outcomes (1)

  • Outcomes of the tetanus patients

    The survival data of tetanus patients.

    2008-01-01~2018-10-31

Secondary Outcomes (1)

  • The hospitalization time.

    2008-01-01~2018-10-31

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study included all patients of all age groups and both sexes who presented with a clinical diagnosis of tetanus.

You may qualify if:

  • This study included all patients of all age groups and both sexes who presented with a clinical diagnosis of tetanus.

You may not qualify if:

  • None.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Provincial Hospital

Fuzhou, Fujian, 350000, China

Location

MeSH Terms

Conditions

Tetanus

Condition Hierarchy (Ancestors)

Clostridium InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director of the Physician

Study Record Dates

First Submitted

November 13, 2019

First Posted

November 18, 2019

Study Start

July 1, 2018

Primary Completion

September 30, 2019

Study Completion

October 31, 2019

Last Updated

November 18, 2019

Record last verified: 2019-11

Locations

CN(1)